Building 2 - Phase 1, Elevate Quarter, Stevenage, SG1 2NY

Description
The new and expanded campus will provide a world-class landscaped setting with a range of amenities and facilities. Health, well-being and inclusivity are at the heart of our design philosophy, alongside our efforts to minimise the impact we have on the planet.

Phase 1, with a target completion date of Q1 2026, comprises two purposed built laboratory buildings; Building 2 totalling 79,922 sq ft (GIA) and Building 4 totalling 119,533 sq ft (GIA). Phase 1 will also deliver a brand new multi-storey Carpark for the site.

Location
Stevenage is the largest cluster of cell and gene therapy companies outside of the US and third largest in the world. The growing cluster has delivered over 1,000 jobs and is home to over 45 companies. Stevenage is strategically located within between Cambridge and London.

Located at the heart of the Forge_Kn Ecosystem, Elevate Quarter is anchored by GSK’s global R&D headquarters employing 7,000 people and extending to 600,000 sq ft of Life Science space alongside the UK’s Cell and Gene Therapy Catapult, Stevenage Bioscience Catalyst, and The Assembly Advanced Manufacturing Cluster.

Kings Cross, Knowledge Quarter is 33 minutes South and Cambridge Biomedical Campus 36 minutes away to the North.

Specifications
- Floor-to-Floor Height - 4.2m
- Structural Grid - 6.6 x 7.5m
- Vibration Criteria - RF<1 (upper floors), VC-A (ground floor)
- Gas Provision - House gas system, external bulk LN2 and bottle gas storage
- Lab / Office 60:40
- Structural Loadings - Live: 5kn/m2, Partitions: 0.8kn/m2
- Ducted Fume Cupboard Provision: 1no 1800mm wide FC per 4500 sq ft
- Structural Approach - RC Frame 350mm slab thickness
- Sprinklers and backup generator provision
- Floors can be split to accommodate multiple occupiers